These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 16244071)

  • 41. [Preparation of monoclonal antibodies against VP2 protein of Asia I type foot-and-mouth disease virus and establishment of a competitive ELISA for the detection of antibodies].
    Xiang M; Zhang K; Lu S; Cai L; Luo Y; Zhang J; He H; Wang Q; Wu B
    Sheng Wu Gong Cheng Xue Bao; 2008 Sep; 24(9):1664-9. PubMed ID: 19160854
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [The occurrence of transmissible spongiform encephalopathies in roe deer (Capreolus capreolus), red deer (Cervus elaphus) and chamois (Rupicapra rupicapra) in Bavaria].
    Schwaiger K; Stierstorfer B; Schmahl W; Bauer J
    Berl Munch Tierarztl Wochenschr; 2004; 117(1-2):24-9. PubMed ID: 14964120
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Determinants of tick-borne encephalitis virus antibody presence in roe deer (Capreolus capreolus) sera.
    Kiffner C; Vor T; Hagedorn P; Niedrig M; Rühe F
    Med Vet Entomol; 2012 Mar; 26(1):18-25. PubMed ID: 21592155
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Identification of a major antibody binding epitope in the non-structural protein 3D of foot-and-mouth disease virus in cattle and the development of a monoclonal antibody with diagnostic applications.
    Yang M; Clavijo A; Li M; Hole K; Holland H; Wang H; Deng MY
    J Immunol Methods; 2007 Apr; 321(1-2):174-81. PubMed ID: 17320098
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Comparable sensitivity and specificity in three commercially available ELISAs to differentiate between cattle infected with or vaccinated against foot-and-mouth disease virus.
    Moonen P; van der Linde E; Chénard G; Dekker A
    Vet Microbiol; 2004 Apr; 99(2):93-101. PubMed ID: 15019100
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Surveillance of foot-and-mouth disease (FMD) in susceptible wildlife and domestic ungulates in Southeast of Bulgaria following a FMD case in wild boar.
    Alexandrov T; Stefanov D; Kamenov P; Miteva A; Khomenko S; Sumption K; Meyer-Gerbaulet H; Depner K
    Vet Microbiol; 2013 Sep; 166(1-2):84-90. PubMed ID: 23830685
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Reintroduction of foot-and-mouth disease in Argentina: characterisation of the isolates and development of tools for the control and eradication of the disease.
    Mattion N; König G; Seki C; Smitsaart E; Maradei E; Robiolo B; Duffy S; León E; Piccone M; Sadir A; Bottini R; Cosentino B; Falczuk A; Maresca R; Periolo O; Bellinzoni R; Espinoza A; Torre JL; Palma EL
    Vaccine; 2004 Oct; 22(31-32):4149-62. PubMed ID: 15474705
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Comparison of sensitivity and specificity in three commercial foot-and-mouth disease virus non-structural protein ELISA kits with swine sera in Taiwan.
    Chen SP; Ellis TM; Lee MC; Cheng IC; Yang PC; Lin YL; Jong MH; Robertson ID; Edwards JR
    Vet Microbiol; 2007 Jan; 119(2-4):164-72. PubMed ID: 17112687
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Expression of the major epitope regions of 2C integrated with the 3AB non-structural protein of foot-and-mouth disease virus and its potential for differentiating infected from vaccinated animals.
    Lu Z; Zhang X; Fu Y; Cao Y; Tian M; Sun P; Li D; Liu Z; Xie Q
    J Virol Methods; 2010 Dec; 170(1-2):128-33. PubMed ID: 20863858
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Multiplexed detection of antibodies to nonstructural proteins of foot-and-mouth disease virus.
    Perkins J; Clavijo A; Hindson BJ; Lenhoff RJ; McBride MT
    Anal Chem; 2006 Aug; 78(15):5462-8. PubMed ID: 16878883
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Development of foot-and-mouth disease virus (FMDV) serotype O virus-like-particles (VLPs) vaccine and evaluation of its potency.
    Mohana Subramanian B; Madhanmohan M; Sriraman R; Chandrasekhar Reddy RV; Yuvaraj S; Manikumar K; Rajalakshmi S; Nagendrakumar SB; Rana SK; Srinivasan VA
    Antiviral Res; 2012 Dec; 96(3):288-95. PubMed ID: 23043941
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Comparison of immune responses after intra-typic heterologous and homologous vaccination against foot-and-mouth disease virus infection in pigs.
    Eblé PL; de Bruin MG; Bouma A; van Hemert-Kluitenberg F; Dekker A
    Vaccine; 2006 Feb; 24(9):1274-81. PubMed ID: 16289709
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Foot-and-mouth disease virus infection in young lambs: pathogenesis and tissue tropism.
    Ryan E; Horsington J; Durand S; Brooks H; Alexandersen S; Brownlie J; Zhang Z
    Vet Microbiol; 2008 Mar; 127(3-4):258-74. PubMed ID: 17942248
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Using wild white-tailed deer to detect eastern equine encephalitis virus activity in Maine.
    Mutebi JP; Lubelczyk C; Eisen R; Panella N; Macmillan K; Godsey M; Swope B; Young G; Smith RP; Kantar L; Robinson S; Sears S
    Vector Borne Zoonotic Dis; 2011 Oct; 11(10):1403-9. PubMed ID: 21736489
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Immune responses of recombinant adenovirus co-expressing VP1 of foot-and-mouth disease virus and porcine interferon alpha in mice and guinea pigs.
    Du Y; Dai J; Li Y; Li C; Qi J; Duan S; Jiang P
    Vet Immunol Immunopathol; 2008 Aug; 124(3-4):274-83. PubMed ID: 18511133
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Some guidelines for determining foot-and-mouth disease vaccine strain matching by serology.
    Mattion N; Goris N; Willems T; Robiolo B; Maradei E; Beascoechea CP; Perez A; Smitsaart E; Fondevila N; Palma E; De Clercq K; La Torre J
    Vaccine; 2009 Jan; 27(5):741-7. PubMed ID: 19041355
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Analysis of the immune response to FMDV structural and non-structural proteins in cattle in Argentina by the combined use of liquid phase and 3ABC-ELISA tests.
    Robiolo B; Seki C; Fondevilla N; Grigera P; Scodeller E; Periolo O; La Torre J; Mattion N
    Vaccine; 2006 Feb; 24(7):997-1008. PubMed ID: 16171905
    [TBL] [Abstract][Full Text] [Related]  

  • 58. FOOT-AND-MOUTH DISEASE IN EXPERIMENTALLY INFECTED MULE DEER (
    Rhyan J; McCollum M; Gidlewski T; Shalev M; Ward G; Donahue B; Arzt J; Stenfeldt C; Mohamed F; Nol P; Deng M; Metwally S; Salman M
    J Wildl Dis; 2020 Jan; 56(1):93-104. PubMed ID: 31329525
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Experimental infection of European red deer (Cervus elaphus) with bluetongue virus serotypes 1 and 8.
    López-Olvera JR; Falconi C; Férnandez-Pacheco P; Fernández-Pinero J; Sánchez MA; Palma A; Herruzo I; Vicente J; Jiménez-Clavero MA; Arias M; Sánchez-Vizcaíno JM; Gortázar C
    Vet Microbiol; 2010 Sep; 145(1-2):148-52. PubMed ID: 20395075
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Serologic detection of bluetongue virus infection of black-tailed deer: comparison of serum neutralization, agar gel immunodiffusion, and competitive ELISA assays.
    Patton JF; Work TM; Jessup DA; Hietala SK; Oliver MN; Maclachlan NJ
    J Wildl Dis; 1994 Jan; 30(1):99-102. PubMed ID: 8151833
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.